サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1666250

北米のドライアイ製品市場：2031年までの予測 - 地域別分析 - 製品別、剤形別、タイプ別、流通チャネル別

North America Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product, Dosage Form, Type, and Distribution Channel

出版日
ページ情報
英文 104 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
北米のドライアイ製品市場：2031年までの予測 - 地域別分析 - 製品別、剤形別、タイプ別、流通チャネル別
出版日: 2025年01月13日
発行: The Insight Partners
ページ情報: 英文 104 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のドライアイ製品市場は、2023年に38億2,536万米ドルとなり、2031年までには55億8,777万米ドルに達すると予測され、2023年から2031年までのCAGRは4.9%と推定されます。

ドライアイの有病率の上昇が北米のドライアイ製品市場を後押し

ドライアイ（DED）は、眼科クリニックを受診する最も一般的な理由の中で、屈折異常、白内障に次いでそれぞれ第3位にランクされています。ドライアイの有病率は先進国で特に増加しています。ドライアイは、不快感、刺激、視覚障害をもたらす複数の要因によって引き起こされます。米国眼科学会が発表した論文によると、DEDは世界中で約11人に1人が罹患しており、その有病率は様々な年齢層で5%から50%に及ぶといいます。2022年のAlconのプレスリリースによると、この疾患は世界で7億1,900万人、米国で3,800万人が罹患しています。

糖尿病網膜症によって網膜に引き起こされる進行性の障害は、さらにDEDを引き起こします。米国眼科学会（American Academy of Ophthalmology）が発表した論文によると、2030年までに全世界で1億9,100万人が糖尿病網膜症に罹患すると推定されています。米国疾病予防管理センター（CDC）によると、米国では2021年に約960万人（全年齢層）が糖尿病網膜症を患っています。このように、糖尿病性網膜症の罹患率の増加がドライアイ製品市場の成長を促進しています。

北米のドライアイ製品市場概要

北米のドライアイ製品市場は、米国、カナダ、メキシコに区分されます。この地域の市場成長の背景には、ドライアイ疾患（DED）に対する意識の高まり、高齢化人口の増加、技術の進歩、眼疾患患者の増加があります。さらに、新薬の頻繁な発売により様々な薬剤が容易に入手できることも、同地域のドライアイ製品市場の成長を後押しする重要な要因の1つです。

DEDは米国では一般的な疾患ですが、十分に診断されておらず、人口年齢の増加がこの疾患の有病率の急上昇に関連している可能性があります。米国疾病予防管理センター（CDC）によると、白内障、黄斑変性症、糖尿病網膜症、緑内障などの加齢に伴う眼疾患が、米国における失明や視力障害の主な原因となっています。その他の一般的な眼疾患には弱視や斜視があります。ドライアイ疾患は、2030年までに279万人の米国男性が罹患すると予想されています。このように、ドライアイ疾患の罹患率の上昇に伴い、国内では治療用製品に対する需要が高まっています。2021年1月、Kala Pharmaceuticals Inc.はドライアイ症状の短期（最大2週間）治療薬EYSUVIS 0.25%（ロテプレドノールエタボネート点眼液）を発売しました。EYSUVISは現在、米国内の全国および地域の医薬品流通センターで販売されています。

北米のドライアイ製品市場の収益と2031年までの予測（金額）

北米のドライアイ製品市場セグメンテーション

北米のドライアイ製品市場は、製品、剤形、製品タイプ、流通チャネル、国別に分類されます。

製品に基づき、北米のドライアイ製品市場は人工涙液、抗炎症薬、点鼻プラグ、分泌促進薬、経口オメガサプリメント、その他に区分されます。人工涙液セグメントは2023年に北米のドライアイ製品市場で最大のシェアを占めました。さらに、抗炎症薬セグメントは、シクロスポリン、コルチコステロイド、その他に細分化されます。さらに、穿刺プラグセグメントは溶解可能なものと取り外し可能なものに細分化されます。

剤形別では、北米のドライアイ製品市場は点眼薬、ゲル、カプセル・錠剤、その他に区分されます。2023年の北米のドライアイ製品市場シェアは、点眼薬セグメントが最大でした。

製品タイプ別では、北米のドライアイ製品市場はOTCと処方箋に二分されます。2023年にはOTCセグメントが北米のドライアイ製品市場でより大きなシェアを占めました。

流通チャネルに基づいて、北米のドライアイ製品市場は小売薬局、病院薬局、オンライン薬局に分類されます。小売薬局セグメントは2023年に北米のドライアイ製品市場で最大のシェアを占めました。

国別では、北米のドライアイ製品市場は米国、カナダ、メキシコに区分されます。2023年の北米のドライアイ製品市場シェアは米国が独占しました。

Santen Pharmaceutical Co Ltd、Johnson &Johnson、OASIS Medical、URSAPHARM Arzneimittel GmbH、Rohto Pharmaceutical Co Ltd、OCuSOFT Inc、Bausch Health Companies Inc、AbbVie Inc、Prestige Consumer Healthcare Inc、Farmigea SpA、Alcon AG.は、北米のドライアイ製品市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米のドライアイ製品市場：主要市場力学

  • 市場促進要因
    • ドライアイの有病率の上昇
    • 高齢者人口の増加
  • 市場抑制要因
    • 点眼薬の副作用と製品回収
  • 市場機会
    • アイケア啓蒙活動の増加
  • 今後の動向
    • ドライアイ治療薬の継続的調査とパイプラインの成長
  • 促進要因と抑制要因の影響

第5章 ドライアイ製品市場：北米分析

  • 北米のドライアイ製品市場収益、2021年～2031年

第6章 北米のドライアイ製品市場分析：製品別

  • 人工涙液
  • 抗炎症薬
  • パンクタルプラグ
  • 分泌促進剤
  • 経口オメガサプリメント
  • その他

第7章 北米のドライアイ製品市場分析：剤形別

  • 点眼薬
  • ジェル
  • カプセル・錠剤
  • その他

第8章 北米のドライアイ製品市場分析：製品タイプ別

  • 一般用医薬品
  • 処方薬

第9章 北米のドライアイ製品市場分析：流通チャネル別

  • 小売薬局
  • 病院薬局
  • オンライン薬局

第10章 北米のドライアイ製品市場：国別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ

第11章 業界情勢

  • ドライアイ製品市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Santen Pharmaceutical Co Ltd
  • Johnson & Johnson
  • OASIS Medical
  • URSAPHARM Arzneimittel GmbH
  • Rohto Pharmaceutical Co Ltd
  • OCuSOFT Inc.
  • Bausch Health Companies Inc
  • AbbVie Inc
  • Prestige Consumer Healthcare Inc.
  • Farmigea SpA
  • Alcon AG

第13章 付録

図表

List Of Tables

  • Table 1. North America Dry Eye Products Market Segmentation
  • Table 2. North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
  • Table 3. North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
  • Table 4. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 5. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
  • Table 6. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
  • Table 7. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 8. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 9. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 10. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 11. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
  • Table 12. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
  • Table 13. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 14. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 15. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 16. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 17. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
  • Table 18. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
  • Table 19. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 20. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 21. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 22. Recent Organic Growth Strategies in the Dry Eye Products Market
  • Table 23. Recent Inorganic Growth Strategies in the Dry Eye Products Market
  • Table 24. Glossary of Terms

List Of Figures

  • Figure 1. North America Dry Eye Products Market Segmentation, by Country
  • Figure 2. North America Dry Eye Products Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Dry Eye Products Market Revenue (US$ Million), 2021-2031
  • Figure 5. Dry Eye Products Market Share (%) - by Product (2023 and 2031)
  • Figure 6. Artificial Tears: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Anti-Inflammatory Drugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Punctal Plugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Secretagogues: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Oral Omega Supplements: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. North America Dry Eye Products Market Share (%) - by Dosage Form (2023 and 2031)
  • Figure 13. Eye Drops: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Gels: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Capsules and Tablets: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. North America Dry Eye Products Market Share (%) - by Type (2023 and 2031)
  • Figure 18. OTC: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Prescription: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Dry Eye Products Market Share (%) - by Distribution Channel (2023 and 2031)
  • Figure 21. Retail Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Hospital Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Online Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. North America: Dry Eye Products Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 25. North America: Dry Eye Products Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 26. United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Growth Strategies in the Dry Eye Products Market
目次
Product Code: TIPRE00028871

The North America dry eye products market was valued at US$ 3,825.36 million in 2023 and is expected to reach US$ 5,587.77 million by 2031; it is estimated to register a CAGR of 4.9% from 2023 to 2031.

Rising Prevalence of Dry Eye Fuels North America Dry Eye Products Market

Dry eye disease (DED) ranks third among the most common reasons for visits to an ophthalmology clinic after refractive errors and cataracts, respectively. The prevalence of dry eye is particularly rising in developed nations. Dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. According to an article published by the American Academy of Ophthalmology, DED affects approximately 1 in 11 people worldwide, with prevalence ranging from 5% to 50% at various ages. According to a press release by Alcon in 2022, the disease affects ~719 million people globally and ~38 million people in the US.

Progressive damage caused to the retina due to diabetic retinopathy further results in DED. According to an article published by the American Academy of Ophthalmology, ~191.0 million people globally are estimated to suffer from diabetic retinopathy by 2030. As per the Centers for Disease Control and Prevention (CDC), approximately 9.6 million people (across all ages) in the US were living with diabetic retinopathy in 2021. Thus, the increasing incidence of diabetic retinopathy is driving the growth of the dry eye products market.

North America Dry Eye Products Market Overview

The North America dry eye products market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the increasing awareness of dry eyes disease (DED), growing aging population, technological advancements, and rising eye disease cases. Moreover, an easy availability of various drugs due to frequent launches of new drugs is one of the key factors propelling the dry eye products market growth in the region.

DED is a common but underdiagnosed condition in the US, and an increase in the population age can be associated with the surging prevalence of this disease. According to the Centers for Disease Control and Prevention (CDC), age-related eye diseases such as cataract, macular degeneration, diabetic retinopathy, and glaucoma are the primary causes of blindness and impaired vision in the US. Other common eye disorders include amblyopia and strabismus. Dry eye disease is expected to affect as many as 2.79 million US men by 2030. Thus, with the rising incidence of dry eye disease, the demand for therapeutic products is on the rise in the country. In January 2021, Kala Pharmaceuticals Inc. launched EYSUVIS 0.25% (loteprednol etabonate ophthalmic suspension) for the short-term (up to two weeks) treatment of dry eye disease symptoms. EYSUVIS is now available in national and regional pharmaceutical distribution centers across the US.

North America Dry Eye Products Market Revenue and Forecast to 2031 (US$ Million)

North America Dry Eye Products Market Segmentation

The North America dry eye products market is categorized into product, dosage form, type, distribution channel, and country.

Based on product, the North America dry eye products market is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest North America dry eye products market share in 2023. Furthermore, the anti-inflammatory drugs segment is subcategorized into cyclosporine, corticosteroid, and others. Additionally, the punctal plugs segment is subsegmented into dissolvable and removable.

In terms of dosage form, the North America dry eye products market is segmented into eye drops, gel, capsules and tablets, and others. The eye drops segment held the largest North America dry eye products market share in 2023.

By type, the North America dry eye products market is bifurcated into OTC and prescription. The OTC segment held a larger North America dry eye products market share in 2023.

Based on distribution channel, the North America dry eye products market is categorized into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment held the largest North America dry eye products market share in 2023.

By country, the North America dry eye products market is segmented into the US, Canada, and Mexico. The US dominated the North America dry eye products market share in 2023.

Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA, and Alcon AG. are some of the leading companies operating in the North America dry eye products market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Dry Eye Products Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Dry Eye
    • 4.1.2 Upsurge in Geriatric Population
  • 4.2 Market Restraints
    • 4.2.1 Side Effects of Eye Drops and Product Recalls
  • 4.3 Market Opportunities
    • 4.3.1 Increasing Initiatives for Eye Care Awareness
  • 4.4 Future Trends
    • 4.4.1 Ongoing Research and Growing Pipeline for Dry Eye Products
  • 4.5 Impact of Drivers and Restraints:

5. Dry Eye Products Market - North America Analysis

  • 5.1 North America Dry Eye Products Market Revenue (US$ Million), 2021-2031

6. North America Dry Eye Products Market Analysis - by Product

  • 6.1 Overview
  • 6.2 Artificial Tears
    • 6.2.1 Overview
    • 6.2.2 Artificial Tears: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Anti-Inflammatory Drugs
    • 6.3.1 Overview
    • 6.3.2 Anti-Inflammatory Drugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
      • 6.3.2.1 North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
  • 6.4 Punctal Plugs
    • 6.4.1 Overview
    • 6.4.2 Punctal Plugs: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
      • 6.4.2.1 North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
  • 6.5 Secretagogues
    • 6.5.1 Overview
    • 6.5.2 Secretagogues: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.6 Oral Omega Supplements
    • 6.6.1 Overview
    • 6.6.2 Oral Omega Supplements: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Dry Eye Products Market Analysis - by Dosage Form

  • 7.1 Overview
  • 7.2 Eye Drops
    • 7.2.1 Overview
    • 7.2.2 Eye Drops: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Gels
    • 7.3.1 Overview
    • 7.3.2 Gels: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Capsules and Tablets
    • 7.4.1 Overview
    • 7.4.2 Capsules and Tablets: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Dry Eye Products Market Analysis - by Type

  • 8.1 Overview
  • 8.2 OTC
    • 8.2.1 Overview
    • 8.2.2 OTC: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Prescription
    • 8.3.1 Overview
    • 8.3.2 Prescription: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Dry Eye Products Market Analysis - by Distribution Channel

  • 9.1 Overview
  • 9.2 Retail Pharmacies
    • 9.2.1 Overview
    • 9.2.2 Retail Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Online Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Online Pharmacies: North America Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Dry Eye Products Market - Country Analysis

  • 10.1 North America: Dry Eye Products Market
    • 10.1.1 North America: Dry Eye Products Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 United States: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.1.1 United States: Dry Eye Products Market Breakdown, by Product
        • 10.1.1.1.1.1 United States: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
        • 10.1.1.1.1.2 United States: Dry Eye Products Market Breakdown, by Punctal Plugs
        • 10.1.1.1.2 United States: Dry Eye Products Market Breakdown, by Dosage Form
        • 10.1.1.1.3 United States: Dry Eye Products Market Breakdown, by Type
        • 10.1.1.1.4 United States: Dry Eye Products Market Breakdown, by Distribution Channel
      • 10.1.1.2 Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.2.3 Canada: Dry Eye Products Market Breakdown, by Product
        • 10.1.1.2.3.1 Canada: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
        • 10.1.1.2.3.2 Canada: Dry Eye Products Market Breakdown, by Punctal Plugs
        • 10.1.1.2.4 Canada: Dry Eye Products Market Breakdown, by Dosage Form
        • 10.1.1.2.5 Canada: Dry Eye Products Market Breakdown, by Type
        • 10.1.1.2.6 Canada: Dry Eye Products Market Breakdown, by Distribution Channel
      • 10.1.1.3 Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.3.3 Mexico: Dry Eye Products Market Breakdown, by Product
        • 10.1.1.3.3.1 Mexico: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
        • 10.1.1.3.3.2 Mexico: Dry Eye Products Market Breakdown, by Punctal Plugs
        • 10.1.1.3.4 Mexico: Dry Eye Products Market Breakdown, by Dosage Form
        • 10.1.1.3.5 Mexico: Dry Eye Products Market Breakdown, by Type
        • 10.1.1.3.6 Mexico: Dry Eye Products Market Breakdown, by Distribution Channel

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Dry Eye Products Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Santen Pharmaceutical Co Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Johnson & Johnson
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 OASIS Medical
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 URSAPHARM Arzneimittel GmbH
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Rohto Pharmaceutical Co Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 OCuSOFT Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Bausch Health Companies Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 AbbVie Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Prestige Consumer Healthcare Inc.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Farmigea SpA
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Alcon AG
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms